PEDİATRİC MİGRAİNE PATİENTS İN FİNDİNGS
EVALUATİON OF POSTDROME FİNDİNGS İN PEDAİTRİC MİGRAİNE PATİENTS
1 other identifier
observational
45
1 country
1
Brief Summary
Migraine is a common neurological disease in the pediatric population. However, studies investigating the clinical symptoms associated with the different phases of migraine attacks (prodrome, aura, postdrome), particularly in childhood and adolescence, remain limited. The aim of this study was to evaluate the clinical symptoms experienced by children with migraine during attack phases (prodrome, aura, postdrome) and to investigate potential differences in these symptoms according to age and gender The first 18 questions assessed sociodemographic variables, including age, sex, body weight, parental characteristics, social status, age at migraine diagnosis and symptoms, knowledge of migraine, family history of migraine, comorbid conditions, and access to healthcare services. The second part of the questionnaire consisted of questions on headache and migraine-related symptoms and clinical characteristics (questions 19-26), migraine treatment (questions 28-34), and postdrome features (questions 35-39). The study examined migraine-related symptoms and clinical characteristics, treatment approaches, and the influence of sex and age group on the stages of migraine. All patients underwent an assessment of headaches within the last three months, along with physical and neurological examinations. The diagnosis of migraine was made according to the ICHD-III criteria.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedFirst Submitted
Initial submission to the registry
May 7, 2026
CompletedFirst Posted
Study publicly available on registry
May 18, 2026
CompletedMay 18, 2026
May 1, 2026
5 months
May 7, 2026
May 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reporting post-migraine symptoms according to age and gender.
The aim of this study is to report clinical findings observed during the postdrome period (prodrome, aura, and headache) and at other times following childhood migraine attacks, according to gender and age.
Between 01.04.2021 and 01.09.2021
Study Arms (1)
Pediatric Migraine Patients
Patients with non-migraine primary headaches, hemiplegic migraine, medication overuse, language or cognitive impairments, medical or psychiatric disorders, those older than 18 years of age, and those who were unwilling to participate in the study were exclude
Eligibility Criteria
Pediatric migraine
You may not qualify if:
- Primary headaches
- Hemiplegic migraine
- Depression
- Anxiety
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Balikesir University
Balıkesir, 10145, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Prof
Study Record Dates
First Submitted
May 7, 2026
First Posted
May 18, 2026
Study Start
April 1, 2021
Primary Completion
September 1, 2021
Study Completion
December 1, 2021
Last Updated
May 18, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
special sensitive population